ClinConnect ClinConnect Logo
Search / Trial NCT06858020

NoPro - Norwegian Hernia Prophylaxis Study

Launched by SYKEHUSET INNLANDET HF · Feb 28, 2025

Trial Information

Current as of June 04, 2025

Recruiting

Keywords

Prophylactic Mesh Onlay Incisional Hernia Midline Laparotomy

ClinConnect Summary

The NoPro study is a clinical trial designed to learn more about preventing incisional hernias, which can occur after surgery involving a midline incision in the abdomen. Researchers are comparing two methods of closing the incision: one using a small-bite suture technique alone, and the other using the same technique but with an additional layer of protective mesh. The main goal is to see how many patients develop an incisional hernia within one year after their surgery.

You may be eligible to participate in this trial if you are at least 18 years old and are scheduled for surgery that involves a midline incision with delayed closure. It’s important to note that the study is open to all genders, and participants must provide written consent. If you join the study, you’ll be randomly assigned to one of the two closing methods, and researchers will monitor your recovery and any complications over the year. This research could help improve surgical care and quality of life for future patients undergoing similar procedures.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Surgery predominantly done my midline laparotomy
  • Age 18 years old or older
  • Written consent by patient/family
  • Midline laparotomy with delayed closure
  • No exclusion criteria
  • Exclusion Criteria:
  • Age under 18 years
  • Pregnancy
  • Previous abdominal midline hernia mesh repair
  • Abdominal compartment syndrome
  • Linea alba closure not possible
  • Life expectancy under six months
  • Hernia in the midline with transverse diameter lager than 2 cm

About Sykehuset Innlandet Hf

Sykehuset Innlandet HF is a prominent healthcare provider in Norway, dedicated to delivering high-quality medical services and advancing clinical research. As a key player in the region's healthcare landscape, the organization operates several hospitals and specialized units, focusing on a wide range of medical disciplines. Sykehuset Innlandet HF is committed to fostering innovative clinical trials that enhance patient care and contribute to the development of new therapies. With a strong emphasis on collaboration and ethical standards, the organization seeks to improve health outcomes through rigorous research and evidence-based practices.

Locations

Hamar, , Norway

Patients applied

0 patients applied

Trial Officials

Lars Martin Rekkedal, MD BBA

Study Chair

Chief of surgery Hamar Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported